TP53 Mutations
Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents
16
TP53 Mutations and Chemotherapy Response to Neoadjuvant Metotrexate, Cisplatin and Adryamicin Chemotherapy in Resected Osteosarcoma
7
Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer
10
TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting
23
Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane- based chemotherapy
13
Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers
12
Molecular Analyses of Early Onset Gastric Cancer in Brazilian Patients: TP53 Mutations, Cadherin Catenin and Mucins Proteins Expression
10
<p>Concurrent TP53 mutations predict poor outcomes of EGFR-TKI treatments in Chinese patients with advanced NSCLC</p>
11
Clinical significance of frequent somatic mutations detected by high throughput targeted sequencing in archived colorectal cancer samples
9
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early onset breast cancer patients
8
Search | Preprints
13
Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection.
35
Prognostic and predictive value of TP53mutations in node positive breast cancer patients treated with anthracycline or anthracycline/taxane based adjuvant therapy: results from the BIG 02 98 phase III trial
13
Missense mutations in the TP53 DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinoma
17
Lobular breast cancer: incidence and genetic and non genetic risk factors
8
Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples
7
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer
11
Chondrosarcoma of the spine: A rare case with unusual presentation
5
NKX2–1 expression as a prognostic marker in early-stage non-small-cell lung cancer
9
Immunohistochemical correlates of TP53 somatic mutations in cancer
11